clotting
Latest
Nanofiber gel and snake venom work together to stop the bleeding
Researchers at Rice University announced a novel use for batroxobin, a hemotoxic component in the venom of two South American pit viper species. They've figured out how to leverage it as a potent coagulant -- when combined with a nanofiber hydrogel called SB50 -- that could save countless lives in surgery. Medical science has actually been employing batroxobin as a topical clotting agent and thrombosis treatment since the mid 1930s. Used along with the gel, now it's shown a capability to stop the flow of blood even if the patient is on heparin, a powerful anticoagulant administered before some surgeries.
